Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04090684 · ClinicalTrials.gov registry record · Phase 1
Ciprofloxacin/Celecoxib Combination in Patients With ALS
A Phase 1 study, sponsored by NeuroSense Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT04090684: Completed Phase 1 study, sponsored by NeuroSense Therapeutics.
NCT04090684 is a Phase 1 study that has completed, run by NeuroSense Therapeutics. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04090684, a Phase 1 study, has completed, sponsored by NeuroSense Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is an open label, off label study, to provide interested ALS patients with Ciprofloxacin/Celecoxib fixed dose combination, while assessing safety and tolerability, routine disease progression measures (ALSFRS-R and Vital Capacity).
Primary Outcome
Treatment emergent adverse event is any medical event associated with the drug
Interventions
- DRUG Fixed dose combination Ciprofloxacin/Celecoxib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-12-09 |
| Est. Completion | 2022-01-20 |
| Phase | Phase 1 |
What the finished NCT04090684 record still lists
NCT04090684 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Fixed dose combination Ciprofloxacin/Celecoxib is the first listed.
NCT04090684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04090684 about?
NCT04090684 is a clinical study titled "Ciprofloxacin/Celecoxib Combination in Patients With ALS". This is an open label, off label study, to provide interested ALS patients with Ciprofloxacin/Celecoxib fixed dose combination, while assessing safety and tolerability, routine disease progression measures (ALSFRS-R and Vital Capacity).
What is the current status of trial NCT04090684?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2019-12-09. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT04090684?
The interventions under investigation include: Fixed dose combination Ciprofloxacin/Celecoxib (DRUG).
Who is sponsoring clinical trial NCT04090684?
This trial is sponsored by NeuroSense Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04090684's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI